Featured News
Weight Loss Drug Removed from Market after Cancer Linked Identified

Eisai, Inc. voluntarily pulled its weight-loss drug Belviq from the market in February 2020 after it was determined that the drug poses a slightly increased risk of cancer. Despite the recall of the product, Eisai said it did not believe the FDA’s interpretation of the latest round of data on the drug’s safety and stated that it still believes the benefits outweigh the risks. According to the FDA, patients currently using Belviq should stop doing so immediately. They should dispose …

Read More
Featured News
More Lawsuits Filed against Maker of Popular Heartburn Medication after April FDA Recall

Additional lawsuits have been filed against the manufacturers of Zantac, a popular medication used to treat heartburn and acid reflux. The new round of legal action comes after the US Food and Drug Administration (FDA) announced on April 1, 2020, that it is requesting manufacturers of the drug to remove it from the market immediately. According to the FDA, the drug puts users at risk for exposure to N-Nitrosodimethylamine (NDMA), a known carcinogen. The use of the medication could result …

Read More
Featured News
Additional Concerns about Valsartan Arise Amid COVID-19 Pandemic

Valsartan is a hypertension medication and used to treat heart failure. It lowers the risk of heart attack. Valsartan blocks angiotensin II from constricting blood vessels. It also reduces high blood pressure by activating aldosterone. It works by binding with angiotensin type I receptors. It’s an antagonist but works differently than other ACE inhibitors drugs that block the conversion of angiotensin I to angiotensin II. In 2019, users of Valsartan began filing lawsuits against the drug’s manufacturer claiming the use …

Read More
Featured News
Claim Filed against Zantac Maker over the Drug’s Link to Cancer

Legal action is underway regarding the potential link between Zantac heartburn medication and cancer. The US Food and Drug Administration (FDA) is investigating Zantac (ranitidine) after it was determined that the popular heartburn and acid reflux medication contains potentially high levels of N-nitrosodimethylamine (NDMA). NDMA is a known carcinogen. As a result of the finding, sales of the drug have been suspended in US stores. Three pharmaceutical companies have issued recalls for their versions of ranitidine. People are exposed to …

Read More
Featured News
FDA Test Reveals Asbestos in Johnson & Johnson Baby Powder

Johnson & Johnson has recalled 33,000 bottles of its baby powder following FDA testing that determined at least one bottle was contaminated with asbestos, a known carcinogen. The recall affects Johnson & Johnson’s brand baby power sourced from China and distributed in 2018…

Read More
Featured News
Denver Doctor Pleading Guilty to Prescribing Holy Trinity Drug Combination

A Denver doctor recently pled guilty to prescribing patients an illegal combination of drugs known as the Holy Trinity. As reported by the Denver Post, Dr. Andrew Mark Ho agreed to 15 years of supervised release and gave up…

Read More
Featured News
How Long Do I Have to File a Lawsuit If I’m Injured by a Drug?

Suffering an injury from a prescription medication you assumed was safe is devastating. Despite claims of effectiveness and safety, prescription drugs hurt people every day. Many of these injuries are serious – some are even fatal. Nothing can give you back the life you had before you were injured by a dangerous drug…

Read More

Top News

heart failure image

Users of the Type 2 diabetes medication Onglyza claim the drug causes heart failure and the drug’s manufacturer knew of the risk and failed to warn consumers. The most recent lawsuit, filed by Texas man Wrendell Chester against Bristol-Myers Squibb and AstraZeneca, claims his heart failure was caused by use of the drug. According to the lawsuit, Chester took Onglyza and Kombiglyze XR between 2010 and 2015. Following his use of the drugs, he suffered congestive heart failure and heart …

heart attack image

Some users of the rheumatoid arthritis drug Actemra are taking legal action against the drug’s manufacturer after their use of it led to cardiovascular incidents. The drug has been linked to reports of stroke, heart attack, and heart failure, as well as incidences of acute pancreatitis and interstitial lung disease. There are concerns that the potentially life threatening side effects linked to Actemra were not disclosed by the drug’s maker or included on the drug’s packaging despite the manufacturer knowing …

Abilify and Gambling
  • By:admin

Users of the antipsychotic medication Abilify might be eligible to receive money from a global settlement reached by the company this past February. According to the court order, issued in mid-February 2019, all lawyers for plaintiffs in the cases will need to appear for a case management conference to resolve the lawsuits pending in federal courts throughout the country. Claims administrators have been appointed to the case and settlement deadlines have been set. The terms of the settlement are private …

oxycodone opioid

The state of New York has filed a lawsuit against Purdue Pharma claiming the pharmaceutical company intentionally triggered the opioid epidemic by way of their marketing campaign. Purdue Pharma recently settled a similar lawsuit and agreed to pay the state of Oklahoma, while a number of other similar lawsuits are pending in courts across the country. OxyContin Marketing Called into Question According to the New York lawsuit, Purdue Pharma’s marketing of its OxyContin painkiller triggered the addiction epidemic faced by …

Atherosclerosis

Tasigna, which also goes by the name nilotinib, is a medication used to treat patients with a specific type of incessant, curable form of leukemia. Many consider it as a last-resort treatment because it is used after other treatment has been unsuccessful. What is Chromosome-positive Chronic Myeloid Leukemia? Chromosome-positive Chronic Myeloid Leukemia (CML) is a type of cancer. It’s curable but can become chronic if not treated properly. It causes a person’s bone marrow to produce too many white blood …

Pancreatic cancer

Byetta, a twice-daily injectable drug prescribed to diabetics to help control blood sugar levels, has been linked to an increased risk for pancreatitis and pancreatic cancer, as well as other health problems. According to lawsuits filed against the manufacturers of the drug, Amylin Pharmaceuticals, Inc. and Bristol-Myers Squibb, Byetta makers failed to properly test the side effects of their drug before seeking approval for sale. Then when problems were discovered with Byetta, the drug’s maker failed to provide adequate warning …

Have you been affected by a drug or device listed?